SUPPORT HOTLINE (888) 901-2226
Donate Now
Title
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT ID: NCT00001823
State: Maryland Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
NCT ID: NCT00579514
State: New York Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Prophylactic Cranial Irradiation (PCI) for Patients With Small Cell Carcinoma of the Urothelium
NCT ID: NCT00756639
State: Texas Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney
NCT ID: NCT00872495
State: Massachusetts Investigator/Sponsoring Organization: Lahey Clinic
Familial and Atypical Urothelial Cancer Registry
NCT ID: NCT00902590
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
NCT ID: NCT00978250
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
PORCH: A Registry of Prospective Outcomes of Radical Cystectomy With or Without Chemotherapy
NCT ID: NCT01776138
State: North Carolina Investigator/Sponsoring Organization: UNC Lineberger Comprehensive Cancer Center
Study of Albumin-bound Rapamycin Nanoparticles (Nab-rapamycin, ABI-009) in the Treatment of BCG Refr...
NCT ID: NCT02009332
State: Multi-State Trial Investigator/Sponsoring Organization: Aadi, LLC
Molecular Correlates of Sensitivity and Resistance to Therapy in Genitourinary Malignancy
NCT ID: NCT01050504
State: Washington Investigator/Sponsoring Organization: University of Washington
Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemot...
NCT ID: NCT00981656
State: Multi-State Trial Investigator/Sponsoring Organization: Radiation Therapy Oncology Group
Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Perfo...
NCT ID: NCT01224665
State: Multi-State Trial Investigator/Sponsoring Organization: Southwest Oncology Group
Study of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tra...
NCT ID: NCT01261728
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Dose Escalation Study of MGA271 in Refractory Cancer
NCT ID: NCT01391143
State: Multi-State Trial Investigator/Sponsoring Organization: MacroGenics
Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancers
NCT ID: NCT01631552
State: Multi-State Trial Investigator/Sponsoring Organization: Immunomedics, Inc.
PK Button Vaporization Electrode for Treatment of Bladder Tumors
NCT ID: NCT01567462
State: Georgia Investigator/Sponsoring Organization: Emory University
Randomized Placebo-Controlled Clinical Trial of Genistein in Reducing the Toxicity and Improving the...
NCT ID: NCT01489813
State: Multi-State Trial Investigator/Sponsoring Organization: Emory University
Study of Romidepsin in Patients With, Lymphomas, Chronic Lymphocytic Leukemia and Select Solid Tumor...
NCT ID: NCT01638533
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Aveluma...
NCT ID: NCT01772004
State: Multi-State Trial Investigator/Sponsoring Organization: EMD Serono
LCCC 1209: Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance I...
NCT ID: NCT01655745
State: North Carolina Investigator/Sponsoring Organization: UNC Lineberger Comprehensive Cancer Center
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
NCT ID: NCT01772771
State: Texas Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer
NCT ID: NCT01840137
State: Michigan Investigator/Sponsoring Organization: University of Michigan
Phase 2 Study Exploring the Efficacy and Safety of Neratinib Therapy in Patients With Solid Tumors ...
NCT ID: NCT01953926
State: Multi-State Trial Investigator/Sponsoring Organization: Puma Biotechnology, Inc.
A Randomized Trial of a Family Caregiver Palliative Care Intervention
NCT ID: NCT01846520
State: California Investigator/Sponsoring Organization: City of Hope Medical Center
Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tol...
NCT ID: NCT01976741
State: Multi-State Trial Investigator/Sponsoring Organization: Bayer
Study of Adjuvant 3D-Conformal Radiotherapy in High Risk Bladder Cancer
NCT ID: NCT01954173
State: Georgia Investigator/Sponsoring Organization: Emory University
Immunopheotype of Locally Advanced Rectal Adenocarcinoma and Its Correlation With the Efficacy of Ne...
NCT ID: NCT02017509
State: Multi-State Trial Investigator/Sponsoring Organization: Providence Health & Services
Integrated Cancer Repository for Cancer Research
NCT ID: NCT02012699
State: Multi-State Trial Investigator/Sponsoring Organization: University of Nebraska
Intravenous CAVATAK™ (Coxsackievirus A21, CVA21) Alone and in Combination With Pembrolizumab in Pati...
NCT ID: NCT02043665
State: Multi-State Trial Investigator/Sponsoring Organization: Viralytics
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
NCT ID: NCT02080650
State: North Carolina Investigator/Sponsoring Organization: Duke University
Biomarker Identification for Bladder Cancer Patients
NCT ID: NCT02053662
State: Ohio Investigator/Sponsoring Organization: Ohio State University Comprehensive Cancer Center
Evaluation of Ferumoxytol Enhanced MRI for the Detection of Lymph Node Metastases in Genitourinary (...
NCT ID: NCT02141490
State: Maryland Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With Non-Muscle ...
NCT ID: NCT02138734
State: Multi-State Trial Investigator/Sponsoring Organization: Altor Bioscience Corporation
Chemoprevention Trial of Weekly Erlotinib Before Bladder Cancer Surgery
NCT ID: NCT02169284
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Bacillus Calmette-Guerin (BCG) Given in Combination With PANVAC[TM] Versus BCG Given Alone in Adults...
NCT ID: NCT02015104
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment of BCG-Refractory Non-mu...
NCT ID: NCT02202772
State: New York Investigator/Sponsoring Organization: James M. McKiernan
Prospective Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to C...
NCT ID: NCT02170181
State: Texas Investigator/Sponsoring Organization: University of Texas Southwestern Medical Center
Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Inv...
NCT ID: NCT02177695
State: Multi-State Trial Investigator/Sponsoring Organization: Southwest Oncology Group
Study to Evaluate the Bioequivalence and Food Effect Bioavailability of CC-486 (Oral Azacitidine) Ta...
NCT ID: NCT02223052
State: Multi-State Trial Investigator/Sponsoring Organization: Celgene
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improv...
NCT ID: NCT02203136
State: Texas Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
Phase II Trial of Estrogen Receptor Targeted Treatment of Non-Muscle Invasive Bladder Cancer With Ta...
NCT ID: NCT02197897
State: Multi-State Trial Investigator/Sponsoring Organization: Baylor College of Medicine
Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients With Advanced Solid Tumors or...
NCT ID: NCT02240238
State: Multi-State Trial Investigator/Sponsoring Organization: NanoCarrier Co., Ltd.
Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts
NCT ID: NCT02246738
State: Pennsylvania Investigator/Sponsoring Organization: Abramson Cancer Center of the University of Pennsylvania
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
NCT ID: NCT02298998
State: Texas Investigator/Sponsoring Organization: The University of Texas Health Science Center at San Antonio
Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) fo...
NCT ID: NCT02281383
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Study of Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
NCT ID: NCT02300610
State: Multi-State Trial Investigator/Sponsoring Organization: H. Lee Moffitt Cancer Center and Research Institute
Study of MK-3475 in Combination With BCG for Patients With High Risk Superficial Bladder Cancer
NCT ID: NCT02324582
State: Multi-State Trial Investigator/Sponsoring Organization: Southern Illinois University
Study Evaluating Safety and Pharmacokinetics of FPA144 in Patients With Advanced Solid Tumors
NCT ID: NCT02318329
State: Multi-State Trial Investigator/Sponsoring Organization: Five Prime Therapeutics, Inc.
Evaluating Local and Regional Immune Responses to Intravesical BCG Administration to Patients With I...
NCT ID: NCT02365207
State: Texas Investigator/Sponsoring Organization: The University of Texas Health Science Center at San Antonio
A Phase 1, Open-label, Dose Escalation Study Of Pf-04518600 As A Single Agent And In Combination Wit...
NCT ID: NCT02315066
State: Multi-State Trial Investigator/Sponsoring Organization: Pfizer
Neoadjuvant Pembrolizumab With Gemcitabine-Cisplatin (Cisplatin-Eligible) or Gemcitabine (Cisplatin-...
NCT ID: NCT02365766
State: Multi-State Trial Investigator/Sponsoring Organization: Christopher Hoimes, M.D.
Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens From Healthy Volunt...
NCT ID: NCT02379429
State: Maryland Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
NCT ID: NCT02400944
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension ...
NCT ID: NCT02420847
State: Texas Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
Study of a p53MVA Vaccine in Combination With Pembrolizumab
NCT ID: NCT02432963
State: California Investigator/Sponsoring Organization: City of Hope Medical Center
Feasibility Trial of MK3475 + Docetaxel or Gemcitabine in Platinum Pre-treated Urothelial Cancer
NCT ID: NCT02437370
State: California Investigator/Sponsoring Organization: University of California, Davis
Prevention of Parastomal Hernia Following Radical Cystectomy and Ileal Conduit Using Biologic Mesh: ...
NCT ID: NCT02439060
State: California Investigator/Sponsoring Organization: University of Southern California
Study of Ramucirumab Plus Pembrolizumab in Patients With Locally Advanced and Unresectable or Metast...
NCT ID: NCT02443324
State: Multi-State Trial Investigator/Sponsoring Organization: Eli Lilly and Company
Study of Regorafenib for Advanced Urothelial Cancer Following Prior Chemotherapy
NCT ID: NCT02459119
State: Multi-State Trial Investigator/Sponsoring Organization: University of Alabama at Birmingham
Study of the Anti-PD-L1 Antibody MPDL3280A in Subjects With Non-metastatic Transitional Cell Carcino...
NCT ID: NCT02451423
State: California Investigator/Sponsoring Organization: University of California, San Francisco
Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Subjects With Non Muscl...
NCT ID: NCT02449239
State: Multi-State Trial Investigator/Sponsoring Organization: Viventia Bio
Ultrasound and Biomarker Tests of Bladder Cancer Invasiveness
NCT ID: NCT02494635
State: California Investigator/Sponsoring Organization: University of Southern California
Study of Cabozantinib Plus Nivolumab (CaboNivo) Alone or in Combination With Ipilimumab (CaboNivoIpi...
NCT ID: NCT02496208
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Met...
NCT ID: NCT02500121
State: Multi-State Trial Investigator/Sponsoring Organization: Matthew Galsky
Study in Patients With Muscle Invasive Bladder Cancer (MIBC) Who Have Progressed on Prior Treatment ...
NCT ID: NCT02546661
State: Multi-State Trial Investigator/Sponsoring Organization: AstraZeneca
Trial of Tissue Factor Specific Antibody Drug Conjugate Tisotumab Vedotin (HuMax®-TF-ADC) in Patient...
NCT ID: NCT02552121
State: Multi-State Trial Investigator/Sponsoring Organization: Genmab
Study of LY3076226, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody-Drug Conjugate, in Patien...
NCT ID: NCT02529553
State: Multi-State Trial Investigator/Sponsoring Organization: Eli Lilly and Company
Study of Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients Wit...
NCT ID: NCT02553642
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without VX-970 in Metastatic Urothelial ...
NCT ID: NCT02567409
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Study of Curcumin and Piperine to Derive a Safe, Optimal Biologic Dose for Ureteral Stent-Induced Sy...
NCT ID: NCT02598726
State: Minnesota Investigator/Sponsoring Organization: Mayo Clinic
Phase II Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Urothelial Cancer
NCT ID: NCT02560038
State: Texas Investigator/Sponsoring Organization: The University of Texas Health Science Center, Houston
Study of Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
NCT ID: NCT02612194
State: North Carolina Investigator/Sponsoring Organization: Earle Burgess
Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab (MK-3475) in Combination Wi...
NCT ID: NCT02619253
State: Multi-State Trial Investigator/Sponsoring Organization: Roberto Pili
Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects With High Risk Non-muscle Invasive Bladde...
NCT ID: NCT02625961
State: Multi-State Trial Investigator/Sponsoring Organization: Merck Sharp & Dohme Corp.
The Effect of Androgen Deprivation Therapy With Enzalutamide on Bladder Cancer Chemoprevention
NCT ID: NCT02605863
State: New York Investigator/Sponsoring Organization: University of Rochester
Phase 1, First-in-Human, Open Label, Dose Escalation Study of MGD009, A Humanized B7-H3 x CD3 Dual-A...
NCT ID: NCT02628535
State: Multi-State Trial Investigator/Sponsoring Organization: MacroGenics
A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab Versus Placebo in Subje...
NCT ID: NCT02632409
State: Multi-State Trial Investigator/Sponsoring Organization: Bristol-Myers Squibb
Study of Enadenotucirev Combined With PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithel...
NCT ID: NCT02636036
State: Multi-State Trial Investigator/Sponsoring Organization: PsiOxus Therapeutics Ltd
Study of In Situ Vaccination With Tremelimumab and IV Durvalumab (MEDI4736) Plus the Toll-like Recep...
NCT ID: NCT02643303
State: Multi-State Trial Investigator/Sponsoring Organization: Ludwig Institute for Cancer Research
A Pilot Study of a Rapid Access Platform for Investigational Drugs (RAPID) in Advanced Cancers
NCT ID: NCT02646319
State: Multi-State Trial Investigator/Sponsoring Organization: Mayo Clinic
Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers
NCT ID: NCT02648178
State: New Hampshire Investigator/Sponsoring Organization: Dartmouth-Hitchcock Medical Center
Optional Sub-study to Intraoperative Imaging With ICG Registry
NCT ID: NCT02651246
State: Pennsylvania Investigator/Sponsoring Organization: Abramson Cancer Center of the University of Pennsylvania
Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystec...
NCT ID: NCT02655081
State: Pennsylvania Investigator/Sponsoring Organization: University of Pittsburgh
Study of CPI-444 as Single Agent and in Combination With Atezolizumab in Patients With Selected Incu...
NCT ID: NCT02655822
State: Multi-State Trial Investigator/Sponsoring Organization: Corvus Pharmaceuticals, Inc.
Study of BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
NCT ID: NCT02657486
State: New York Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Blue Light Cystoscopy With Cysview® Registry
NCT ID: NCT02660645
State: Multi-State Trial Investigator/Sponsoring Organization: Photocure
A Phase 2 Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
NCT ID: NCT02675829
State: New York Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Study of Gemcitabine and Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Prior to Radical Cystec...
NCT ID: NCT02690558
State: North Carolina Investigator/Sponsoring Organization: UNC Lineberger Comprehensive Cancer Center
A Phase II Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in ...
NCT ID: NCT02693717
State: Texas Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
Single Bladder Instillation of Mitomycin C vs. Gemcitabine vs. No Additional Treatment Immediately A...
NCT ID: NCT02695771
State: Multi-State Trial Investigator/Sponsoring Organization: Spectrum Health Hospitals
Risk of Bladder Cancer Between Patients With Type 2 Diabetes Exposed to Dapagliflozin and Those Expo...
NCT ID: NCT02695121
State: Multi-State Trial Investigator/Sponsoring Organization: AstraZeneca
Prospective Randomized Comparison of Robotic Versus Open Radical Cystectomy
NCT ID: NCT02699853
State: California Investigator/Sponsoring Organization: University of Southern California
Observation Versus Immediate Surgery of Low Risk Bladder Cancer
NCT ID: NCT02700724
State: Tennessee Investigator/Sponsoring Organization: Vanderbilt University Medical Center
Identifying Genetic Predictors of Durable Clinical Benefit to Pembrolizumab in Advanced or Recurrent...
NCT ID: NCT02710396
State: Multi-State Trial Investigator/Sponsoring Organization: Naiyer Rizvi
Trimodality Bladder Preservation Therapy: Maximal Transurethral Resection Followed by Accelerated Me...
NCT ID: NCT02710734
State: Pennsylvania Investigator/Sponsoring Organization: Fox Chase Cancer Center
A Phase II Trial of sEphB4-HSA in Combination With Anti PD1 Antibody Pembrolizumab (MK-7435) for Met...
NCT ID: NCT02717156
State: California Investigator/Sponsoring Organization: University of Southern California
The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Inv...
NCT ID: NCT02716623
State: Multi-State Trial Investigator/Sponsoring Organization: University of Kansas Medical Center
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT ID: NCT02745301
State: Tennessee Investigator/Sponsoring Organization: Vanderbilt University
Study Evaluating Safety, Tolerability and Preliminary Efficacy of GemRIS 225 mg in Subjects With Mu...
NCT ID: NCT02722538
State: Multi-State Trial Investigator/Sponsoring Organization: Taris Biomedical LLC
A Pilot Study to Test Rapid Acquisition of Point of Care Ultrasound for Various Applications
NCT ID: NCT02831556
State: North Carolina Investigator/Sponsoring Organization: Duke University
A Phase 1b Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients Wit...
NCT ID: NCT02576665
State: Multi-State Trial Investigator/Sponsoring Organization: Tocagen Inc.
A Pilot Study of Neoadjuvant sEphB4-HSA in Patients With Genitourinary Cancers
NCT ID: NCT02767921
State: California Investigator/Sponsoring Organization: University of Southern California
Randomized Placebo Control Trial of Perioperative Gabapentin to Reduce Total Analgesic Requirements ...
NCT ID: NCT02355886
State: Washington Investigator/Sponsoring Organization: University of Washington
Assessing Near Infrared Fluorescence Imaging Medical Technology for the Detection of Bladder Cancer
NCT ID: NCT03058705
State: New York Investigator/Sponsoring Organization: Edward Messing
Molecular Analysis for Therapy Choice (MATCH)
NCT ID: NCT02465060
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Study Of Avelumab (msb0010718c) Plus Best Supportive Care Versus Best Supportive Care Alone As A Mai...
NCT ID: NCT02603432
State: Multi-State Trial Investigator/Sponsoring Organization: Pfizer
Study to Evaluate the Safety and Efficacy of INSTILADRIN® (rAd-Interferon (IFN)/Syn3) Administered I...
NCT ID: NCT02773849
State: Multi-State Trial Investigator/Sponsoring Organization: FKD Therapies Oy
STUDY OF THE SAFETY AND PHARMACOLOGY OF ATEZOLIZUMAB ADMINISTERED WITH OR WITHOUT BACILLE CALMETTE-G...
NCT ID: NCT02792192
State: Multi-State Trial Investigator/Sponsoring Organization: Hoffmann-La Roche
A Pilot Clinical Trial of Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
NCT ID: NCT02788201
State: Maryland Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Study of Intravesical MK-3475 and Bacillus Calmette-Guerin (BCG) in Subjects With High Risk and BCG-...
NCT ID: NCT02808143
State: Illinois Investigator/Sponsoring Organization: Northwestern University
Study of Atezolizumab (Anti−PD-L1 Antibody) as Monotherapy and in Combination With Platinum-Based Ch...
NCT ID: NCT02807636
State: Multi-State Trial Investigator/Sponsoring Organization: Hoffmann-La Roche
Pre-Surgical Study Evaluating Anti-PD-L1 Antibody (Durvalumab) Plus Anti-CTLA-4 (Tremelimumab) in Pa...
NCT ID: NCT02812420
State: Texas Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry Optional Sub-Study I: ...
NCT ID: NCT02852252
State: Pennsylvania Investigator/Sponsoring Organization: University of Pennsylvania
Pilot Study of Celecoxib Combined With Gemcitabine and Cisplatin for Neoadjuvant Treatment of Locali...
NCT ID: NCT02885974
State: Multi-State Trial Investigator/Sponsoring Organization: Baylor College of Medicine
Steps to Eliminate Postoperative Problems
NCT ID: NCT02880176
State: Pennsylvania Investigator/Sponsoring Organization: University of Pennsylvania
Phase II Study of Nanoparticle Albumin-bound Paclitaxel Plus Gemcitabine as First-line Therapy for t...
NCT ID: NCT02887248
State: Multi-State Trial Investigator/Sponsoring Organization: SCRI Development Innovations, LLC
Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Pati...
NCT ID: NCT02891161
State: Multi-State Trial Investigator/Sponsoring Organization: Monika Joshi, MD
A Phase 1 Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malign...
NCT ID: NCT02897375
State: Georgia Investigator/Sponsoring Organization: Emory University
Study of NEO-PV-01 + Adjuvant With Nivolumab in Patients With Melanoma, Non-Small Cell Lung Carcinom...
NCT ID: NCT02897765
State: Multi-State Trial Investigator/Sponsoring Organization: Neon Therapeutics, Inc.
A Phase 2 Study of Check Point Inhibitor, Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) R...
NCT ID: NCT02901548
State: Florida Investigator/Sponsoring Organization: H. Lee Moffitt Cancer Center and Research Institute
A Prospective, Randomized Trial of Preventive Mesh Placement at the Time of Radical Cystectomy to Re...
NCT ID: NCT02908061
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
NCT ID: NCT02834013
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Intravenous Lidocaine in the Perioperative Setting and the Effects on Postoperative Pain and Bowel F...
NCT ID: NCT02924480
State: West Virginia Investigator/Sponsoring Organization: CAMC Health System
Application-based Perioperative Management of the Radical Cystectomy Patient
NCT ID: NCT02942121
State: Kansas Investigator/Sponsoring Organization: University of Kansas Medical Center
Study of SGN-2FF in Patients With Advanced Solid Tumors
NCT ID: NCT02952989
State: Multi-State Trial Investigator/Sponsoring Organization: Seattle Genetics, Inc.
Electro-Phage and Colorimetric Aptamer Sensors for Clinical Staging and Monitoring of Bladder Cancer
NCT ID: NCT02957370
State: California Investigator/Sponsoring Organization: University of California, Irvine
MK-7684 as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
NCT ID: NCT02964013
State: Multi-State Trial Investigator/Sponsoring Organization: Merck Sharp & Dohme Corp.
Assessment of Reliability of Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladd...
NCT ID: NCT02968732
State: Pennsylvania Investigator/Sponsoring Organization: Fox Chase Cancer Center
Clinical Validation of a Urine-based Assay With Genomic and Epigenomic Markers for Predicting Recurr...
NCT ID: NCT02969109
State: Minnesota Investigator/Sponsoring Organization: Genomic Health®, Inc.
A Clinical Trial To Evaluate Image-Guided Gynecologic Brachytherapy In The MR Simulator Suite
NCT ID: NCT02993900
State: Maryland Investigator/Sponsoring Organization: Sidney Kimmel Comprehensive Cancer Center
Phase 1 Cell Dose Escalation Study to Assess the Safety and Tolerability of Genetically Engineered M...
NCT ID: NCT02989064
State: Multi-State Trial Investigator/Sponsoring Organization: Adaptimmune
A Pilot Safety Study and Single Arm Phase II Study of Gemcitabine and Cisplatin With Atezolizumab (M...
NCT ID: NCT02989584
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Targeting a Genomic Biomarker for PET Imaging and Staging of Urothelial Cancer: A Preliminary Evalua...
NCT ID: NCT03039413
State: Pennsylvania Investigator/Sponsoring Organization: Sidney Kimmel Cancer Center at Thomas Jefferson University
Phase I Study of the Non-receptor Kinase Inhibitor Bosutinib in Combination With Pemetrexed in Patie...
NCT ID: NCT03023319
State: Ohio Investigator/Sponsoring Organization: Nagla Karim
Functional Imaging of T-cell Activation With [18F]F-AraG in Bladder Cancer Patients Receiving Neoadj...
NCT ID: NCT03007719
State: California Investigator/Sponsoring Organization: Lawrence Fong
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
NCT ID: NCT03063125
State: Kansas Investigator/Sponsoring Organization: University of Kansas Medical Center
Comparison of Obturator Nerve Blockade and Neuromuscular Blockade for the Prevention of Adductor Spa...
NCT ID: NCT03063255
State: Florida Investigator/Sponsoring Organization: University of Florida
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell P...
NCT ID: NCT03091660
State: Multi-State Trial Investigator/Sponsoring Organization: Southwest Oncology Group
Study To Evaluate Dna Methlyation Markers For Detection Of Primary Bladder Cancer In Urine Samples ....
NCT ID: NCT03122964
State: Texas Investigator/Sponsoring Organization: MDx Health
Atezolizumab in Combination With Gemcitabine and Cisplatin As First-Line Treatment in Metastatic Uro...
NCT ID: NCT03093922
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics,...
NCT ID: NCT03125200
State: Multi-State Trial Investigator/Sponsoring Organization: ADC Therapeutics S.A.
Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer
NCT ID: NCT03125460
State: Multi-State Trial Investigator/Sponsoring Organization: Cepheid
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
NCT ID: NCT03133286
State: California Investigator/Sponsoring Organization: DxTerity Diagnostics
Phase 1 Dose Escalation, Multi-tumor Study to Assess the Safety, Tolerability and Antitumor Activity...
NCT ID: NCT03132922
State: Multi-State Trial Investigator/Sponsoring Organization: Adaptimmune
LCCC 1636: Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder C...
NCT ID: NCT03156244
State: North Carolina Investigator/Sponsoring Organization: UNC Lineberger Comprehensive Cancer Center
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
NCT ID: NCT03193515
State: Hawaii Investigator/Sponsoring Organization: University of Hawaii
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
NCT ID: NCT03193528
State: Hawaii Investigator/Sponsoring Organization: University of Hawaii
St. Judes-Stanford Comprehensive Support Initiative
NCT ID: NCT03154190
State: California Investigator/Sponsoring Organization: Stanford University
ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
NCT ID: NCT03193541
State: Hawaii Investigator/Sponsoring Organization: University of Hawaii
Measuring Surgical Recovery After Radical Cystectomy
NCT ID: NCT03193970
State: Multi-State Trial Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
MDSC Clinical Assay for Cancer Detection and Monitoring in Bladder Carcinoma
NCT ID: NCT02735512
State: California Investigator/Sponsoring Organization: University of Southern California
A Randomized Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive ...
NCT ID: NCT02753309
State: Texas Investigator/Sponsoring Organization: The University of Texas Health Science Center at San Antonio
Study of TSR-033, an Anti-LAG-3 Monoclonal Antibody, Alone and in Combination With an Anti-PD-1 in P...
NCT ID: NCT03250832
State: Multi-State Trial Investigator/Sponsoring Organization: Tesaro, Inc.
Study of Qapzola™ (Apaziquone) as a Chemotherapy Adjuvant to TransUrEthral Resection of Bladder Tumo...
NCT ID: NCT03224182
State: Pennsylvania Investigator/Sponsoring Organization: Spectrum Pharmaceuticals, Inc
TraceIT TM Hydrogel Tissue Marker for Patients Receiving Definitive Chemoradiation for Bladder Cance...
NCT ID: NCT03125226
State: Washington Investigator/Sponsoring Organization: University of Washington
Trial of Atezolizumab in BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT ID: NCT02844816
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma: A Multice...
NCT ID: NCT02700464
State: Multi-State Trial Investigator/Sponsoring Organization: Nucleix Ltd.
Phase I-II Study of the Treatment of Metastatic Cancer That Expresses MAGE-A3 Using Lymphodepleting ...
NCT ID: NCT02153905
State: Maryland Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Afatinib Dimaleate in Treating Patients With Advanced Refractory Urothelial Cancer
NCT ID: NCT02122172
State: Multi-State Trial Investigator/Sponsoring Organization: University of Chicago
Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
NCT ID: NCT02793128
State: Multi-State Trial Investigator/Sponsoring Organization: UroGen Pharma Ltd.
A Prospective Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery fo...
NCT ID: NCT02412670
State: Multi-State Trial Investigator/Sponsoring Organization: ECOG-ACRIN Cancer Research Group
Study to Evaluate the Activity of Commercially Available Molecularly Matched Targeted Therapies in S...
NCT ID: NCT02795156
State: Multi-State Trial Investigator/Sponsoring Organization: SCRI Development Innovations, LLC
Bladder-Preservation Chemo-Radiotherapy (Partial Bladder Hypo-fractionated Radiotherapy) for Patient...
NCT ID: NCT02688348
State: California Investigator/Sponsoring Organization: Jonsson Comprehensive Cancer Center
UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch: Hoosier Canc...
NCT ID: NCT02643043
State: Multi-State Trial Investigator/Sponsoring Organization: Matthew Milowsky, MD
Oral Supplementation to Enhance Recovery Pilot Study
NCT ID: NCT03204266
State: Texas Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary ...
NCT ID: NCT03134027
State: North Carolina Investigator/Sponsoring Organization: Duke University
Study of B-701 Plus Docetaxel Versus Placebo Plus Docetaxel in the Treatment of Locally Advanced or ...
NCT ID: NCT02401542
State: Multi-State Trial Investigator/Sponsoring Organization: BioClin Therapeutics, Inc.
Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients U...
NCT ID: NCT02145871
State: Multi-State Trial Investigator/Sponsoring Organization: Memorial Sloan Kettering Cancer Center
Study to Evaluate the Activity and Tolerability of the Novel mTOR Inhibitor, MLN0128 (TAK-228), in P...
NCT ID: NCT03047213
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Leukocyte Telomere Length in Bladder Cancer Survivors: Diet and Exercise Trial
NCT ID: NCT03286699
State: Pennsylvania Investigator/Sponsoring Organization: University of Pittsburgh
A Phase IV Investigation of Sugammadex in Outpatient Urological Procedures
NCT ID: NCT03138967
State: Texas Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
Imaging of Bladder Cancer Using Clinical 3 Tesla MRI and EX-VIVO Ultra-High-Field MRI.
NCT ID: NCT00938145
State: Ohio Investigator/Sponsoring Organization: Ohio State University Comprehensive Cancer Center
Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach
NCT ID: NCT00848289
State: Multi-State Trial Investigator/Sponsoring Organization: M.D. Anderson Cancer Center
A Phase II Open Label Single Arm Study of Adjuvant Nivolumab Following Chemo-Radiation in Localized ...
NCT ID: NCT03171025
State: Utah Investigator/Sponsoring Organization: University of Utah
Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, an...
NCT ID: NCT02900248
State: Idaho Investigator/Sponsoring Organization: CureOne
Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Com...
NCT ID: NCT02145390
State: Florida Investigator/Sponsoring Organization: University of Miami
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combinat...
NCT ID: NCT03022825
State: Multi-State Trial Investigator/Sponsoring Organization: Altor BioScience
A Phase I Study to Evaluate the Safety of Trigriluzole (FC-4157/BHV-4157) in Combination With PD-1 B...
NCT ID: NCT03229278
State: New Jersey Investigator/Sponsoring Organization: Rutgers, The State University of New Jersey
Study of Enfortumab Vedotin (ASG-22CE) in Combination With Immune Checkpoint Inhibitor (CPI) Therapy...
NCT ID: NCT03288545
State: Multi-State Trial Investigator/Sponsoring Organization: Astellas Pharma Global Development, Inc.
Study of the Combination of Durvalumab (MEDI4736) and Vicinium (Oportuzumab Monatox, VB4-845) in Sub...
NCT ID: NCT03258593
State: Maryland Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination With Atezolizumab in P...
NCT ID: NCT03289962
State: Multi-State Trial Investigator/Sponsoring Organization: Genentech, Inc.
Evaluation of the Performance of a Disposable Cystoscope System for Direct Visualization of the Uret...
NCT ID: NCT03331705
State: Nevada Investigator/Sponsoring Organization: UroSee Corporation
A Phase 1, Open-Label, Dose Escalation Study of PRS-343 in Patients With HER2-Positive Advanced or M...
NCT ID: NCT03330561
State: Multi-State Trial Investigator/Sponsoring Organization: Pieris Pharmaceuticals, Inc.
Doses of the Arginase Inhibitor INCB001158 (Formerly Known as CB1158) as a Single Agent and in Combi...
NCT ID: NCT02903914
State: Multi-State Trial Investigator/Sponsoring Organization: Incyte Corporation
Novel FGFR3 Inhibitor (B-701) Combined With Atezolizumab in Subjects With Locally Advanced or Metast...
NCT ID: NCT03123055
State: Multi-State Trial Investigator/Sponsoring Organization: BioClin Therapeutics, Inc.
Safety and Preliminary Efficacy of NKTR 214 and Anti-PD-L1 (Atezolizumab) in Patients With Locally A...
NCT ID: NCT03138889
State: Multi-State Trial Investigator/Sponsoring Organization: Nektar Therapeutics
A Single-arm, Open-label, Multicenter Study of Enfortumab Vedotin (ASG-22CE) for Treatment of Patien...
NCT ID: NCT03219333
State: Multi-State Trial Investigator/Sponsoring Organization: Astellas Pharma Global Development, Inc.
Trial of MK3475 in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as...
NCT ID: NCT02621151
State: Multi-State Trial Investigator/Sponsoring Organization: New York University School of Medicine
Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanc...
NCT ID: NCT03244384
State: Multi-State Trial Investigator/Sponsoring Organization: National Cancer Institute (NCI)
Tissue Factor Specific Antibody Drug Conjugate Tisotumab Vedotin (HuMax® TF ADC) in Patients With Lo...
NCT ID: NCT02001623
State: Multi-State Trial Investigator/Sponsoring Organization: Genmab
High Resolution Imaging for Early and Better Detection of Bladder Cancer
NCT ID: NCT02340650
State: Texas Investigator/Sponsoring Organization: The University of Texas Health Science Center, Houston
Avelumab (msb0010718c) In Combination With Other Cancer Immunotherapies In Patients With Advanced Ma...
NCT ID: NCT02554812
State: Multi-State Trial Investigator/Sponsoring Organization: Pfizer